Related Experiment Video

Updated: Jan 13, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

615

The pathological role and prognostic impact of miR-181 in acute myeloid leukemia

Hengyou Weng1, Kumar Lal2, Frank F Yang3

  • 1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.

Cancer Genetics
|February 18, 2015
PubMed

Insights

MicroRNA-181 (miR-181) is crucial in acute myeloid leukemia (AML) development. This microRNA (miRNA) acts as a tumor suppressor, impacting patient survival and offering potential as a diagnostic marker and therapeutic target.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Epigenetic modifications, including DNA methylation and histone modifications, are vital in acute myeloid leukemia (AML) leukemogenesis.
  • MicroRNA (miRNA) regulation represents a significant layer of epigenetic regulation.
  • The miR-181 family, expressed in hematopoietic cells, influences normal hematopoiesis and is implicated in AML pathogenesis and prognosis.

Purpose of the Study:

  • To review the role of miR-181 in acute myeloid leukemia (AML).
  • To explore miR-181's potential as a diagnostic marker and prognostic predictor in AML.
  • To discuss miR-181 as a potential therapeutic target for AML.

Main Methods:

  • Literature review of studies investigating miR-181 in AML.
  • Analysis of evidence regarding miR-181's function in leukemogenesis.
  • Evaluation of miR-181's impact on patient survival and diagnostic/prognostic value.

Main Results:

  • miR-181 acts as a tumor suppressor in AML pathogenesis.
  • miR-181 significantly impacts the survival of patients with AML.
  • The miR-181 family plays a role in normal hematopoietic cell differentiation.

Conclusions:

  • miR-181 is a critical factor in AML development and progression.
  • miR-181 holds promise as a diagnostic and prognostic biomarker for AML.
  • Targeting miR-181 presents a potential therapeutic strategy for AML treatment.
Keywords:
Acute myeloid leukemiadiagnostic markermiR-181prognostic predictortumor suppressor

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K